APT Medical Inc. (SHA:688617)

Market Cap	39.43B
Revenue (ttm)	2.17B
Net Income (ttm)	716.16M
Shares Out	141.01M
EPS (ttm)	5.08
PE Ratio	55.08
Forward PE	44.13
Dividend	1.21 (0.42%)
Ex-Dividend Date	Jun 19, 2025

Volume	725,243
Average Volume	835,485
Open	284.36
Previous Close	284.53
Day's Range	279.13 - 286.68
52-Week Range	213.88 - 331.03
Beta	-0.31
RSI	38.82
Earnings Date	Aug 22, 2025

About Chimerix

APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guid...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,555
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. Earnings were 673.15 million, an increase of 26.08%.